Interazioni tra farmaci
Arformoterol + Indacaterol-glycopyrronium
Gravità: Maggiore
Arformoterol and Indacaterol-glycopyrronium: major interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Both agents are inhaled long-acting beta-2 agonists (indacaterol is one component of the combination), so using them together duplicates therapy and adds to beta-adrenergic cardiovascular effects. This can cause tachycardia, hypokalemia, QTc prolongation and arrhythmia.
Cosa significa questa interazione in parole semplici
Arformoterol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Arformoterol belongs to Respiratory; Indacaterol-glycopyrronium belongs to Respiratory.
Perché avviene
Additive beta-2 adrenergic stimulation leading to hypokalemia, tachycardia and QT prolongation.
Cosa fare
Avoid concurrent use of two long-acting beta-agonists and keep a single LABA-containing regimen. If a switch is made, stop one agent and monitor heart rate, potassium and ECG as indicated.
Cosa chiedere al farmacista
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Arformoterol e Indacaterol-glycopyrronium, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altre interazioni di Indacaterol-glycopyrronium
Altre interazioni di Arformoterol
- Arformoterol + Budesonide-formoterol Maggiore
- Arformoterol + Carvedilol Maggiore
- Arformoterol + Cisapride Maggiore
- Arformoterol + Desipramine Maggiore
- Arformoterol + Fluticasone-salmeterol Maggiore
- Arformoterol + Fluticasone-vilanterol Maggiore
Domande frequenti
Can I take Arformoterol with Indacaterol-glycopyrronium?
MediHelp rates the interaction as major. Arformoterol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents are inhaled long-acting beta-2 agonists (indacaterol is one component of the combination), so using them together duplicates therapy and adds to beta-adrenergic cardiovascular effects. This can cause tachycardia, hypokalemia, QTc prolongation and arrhythmia.
How serious is the interaction between Arformoterol and Indacaterol-glycopyrronium?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use of two long-acting beta-agonists and keep a single LABA-containing regimen. If a switch is made, stop one agent and monitor heart rate, potassium and ECG as indicated.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arsenic trioxide, Betaxolol. The full list is on the Indacaterol-glycopyrronium page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
